Racial variation in autosomal dominant polycystic kidney disease

被引:18
|
作者
Freedman, BI
Soucie, JM
Chapman, A
Krisher, J
McClellan, WM
机构
[1] Wake Forest Univ, Sch Med, Dept Internal Med Nephrol, Winston Salem, NC 27157 USA
[2] Emory Univ, Sch Publ Hlth, Dept Epidemiol, Atlanta, GA USA
[3] Emory Univ, Sch Med, Dept Internal Med Nephrol, Atlanta, GA USA
[4] SE Kidney Council Inc, ESRD Network 6, Raleigh, NC USA
[5] Emory Univ, Sch Med, Dept Internal Med, Atlanta, GA USA
[6] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA USA
关键词
autosomal dominant polycystic kidney disease (ADPKD); end-stage renal disease (ESRD); chronic kidney failure; race; blacks; familial clustering;
D O I
10.1016/S0272-6386(00)70298-8
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
These analyses were undertaken to determine whether racial variation contributes to the risk of end-stage renal disease (ESRD) in close relatives of incident dialysis patients with autosomal dominant polycystic kidney disease (ADPKD)-associated ESRD, A family history of ESRD was recorded in 14,769 incident ESRD patients in Network 6 (Georgia, North Carolina, South Carolina) between September 1993 and November 1997, Two hundred thirty-seven patients with ADPKD-ESRD comprised the study population (180 white and 57 black), Differences in patient populations were analyzed using the chi-squared and Student's t-tests, and multiple regression analysis was performed. Correlation in age at ESRD onset in families was performed by linear regression analysis. A positive family history (FH) of ESRD in first- or second-degree relatives was reported by 38.6% (22 of 57) of blacks and 55% (99 of 180) of whites (P = 0.03), The 22 blacks with a positive FH had a mean of 2.0 additional ESRD relatives and 10.4 total first-degree relatives, whereas the 99 whites with a positive FH had a mean of 2.6 additional ESRD relatives and 7.0 total first-degree relatives (P = 0.14 and P < 0.001, respectively). Mean age in years at first dialysis was similar in blacks and whites, regardless of FH (black FH positive, 63.8; black FH negative, 66.3; P = 0.66; white FH positive, 60.8; white FH negative, 62.8; P = 0.48), On average, 57.9% of the first- and second-degree relatives of white cases had ADPKD-associated ESRD, compared with 28.6% of the relatives of black cases (P < 0.001), In the multivariate analysis, white race (P = 0.004) and increasing family size (P = 0.002) were positively correlated with the number of relatives having ADPKD-associated ESRD, whereas age at ESRD onset (P = 0.50) and gender (P = 0.94) were not. Age at onset of ESRD was correlated within members of multiply affected white (P < 0.001) but not black families (P = 0.80), We conclude that blacks with ADPKD-associated ESRD are less likely than whites to have relatives with ESRD, and there is no correlation in age at onset of ADPKD-ESRD in black families. (C) 2000 by the National Kidney Foundation, Inc.
引用
收藏
页码:35 / 39
页数:5
相关论文
共 50 条
  • [21] ESRD From Autosomal Dominant Polycystic Kidney Disease in the United States, 2001-2010
    Reule, Scott
    Sexton, Donal J.
    Solid, Craig A.
    Chen, Shu-Cheng
    Collins, Allan J.
    Foley, Robert N.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2014, 64 (04) : 592 - 599
  • [22] Total Kidney Volume in Autosomal Dominant Polycystic Kidney Disease: A Biomarker of Disease Progression and Therapeutic Efficacy
    Alam, Ahsan
    Dahl, Neera K.
    Lipschutz, Joshua H.
    Rossetti, Sandro
    Smith, Patricia
    Sapir, Daniel
    Weinstein, Jordan
    McFarlane, Philip
    Bichet, Daniel G.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2015, 66 (04) : 564 - 576
  • [23] Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD) in the United States
    McGill, Rita L.
    Saunders, Milda R.
    Hayward, Alexandra L.
    Chapman, Arlene B.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 17 (07): : 976 - 985
  • [24] Effects of cholecalciferol supplementation in Autosomal Dominant Polycystic Kidney Disease (ADPKD) patients
    Vendramini, Larissa Collis
    Rodrigues, Fernanda Guedes
    Dalboni, Maria Aparecida
    de Carvalho Junior, Jose Tarcisio Giffoni
    Batista, Marcelo da Costa
    Nishiura, Jose Luiz
    Heilberg, Ita Pfeferman
    HUMAN NUTRITION & METABOLISM, 2021, 24
  • [25] Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease
    Hiyama, L
    Tang, A
    Miller, LG
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2006, 47 (01) : e9 - e13
  • [26] Mainstreaming Genetic Testing for Adult Patients With Autosomal Dominant Polycystic Kidney Disease
    Elliott, Mark D.
    James, Leslie C.
    Simms, Emily L.
    Sharma, Priyana
    Girard, Louis P.
    Cheema, Kim
    Elliott, Meghan J.
    Lauzon, Julie L.
    Chun, Justin
    CANADIAN JOURNAL OF KIDNEY HEALTH AND DISEASE, 2021, 8
  • [27] Renal Ultrasonographic Evaluation in Children at Risk of Autosomal Dominant Polycystic Kidney Disease
    Reed, Berenice
    Nobakht, Ehsan
    Dadgar, Sherry
    Bekheirnia, Mir Reza
    Masoumi, Amirali
    Belibi, Frank
    Yan, Xiang Dong
    Cadnapaphornchai, Melissa
    Schrier, Robert W.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2010, 56 (01) : 50 - 56
  • [28] Safety and tolerability of sirolimus treatment in patients with autosomal dominant polycystic kidney disease
    Serra, Andreas L.
    Kistler, Andreas D.
    Poster, Diane
    Krauer, Fabienne
    Senn, Oliver
    Raina, Shagun
    Pavik, Ivana
    Rentsch, Katharina
    Regeniter, Axel
    Weishaupt, Dominik
    Wuethrich, Rudolf P.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2009, 24 (11) : 3334 - 3342
  • [29] Metabolic Reprogramming in Autosomal Dominant Polycystic Kidney Disease: Evidence and Therapeutic Potential
    Nowak, Kristen L.
    Hopp, Katharina
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (04): : 577 - 584
  • [30] Familial clustering of ruptured intracranial aneurysms in autosomal dominant polycystic kidney disease
    Belz, MM
    Hughes, RL
    Kaehny, WD
    Johnson, AM
    Fick-Brosnahan, GM
    Earnest, MP
    Gabow, PA
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : 770 - 776